As filed with the Securities and Exchange Commission on November 14, 2016
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
TTM Technologies, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
91-1033443
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
1665 Scenic Avenue, Suite 250
Costa Mesa, California 92626
(714) 327-3000
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Daniel J.
Weber, Esq.
Senior Vice President and General Counsel
TTM Technologies, Inc.
1665 Scenic Avenue, Suite 250
Costa Mesa, California 92626
(714) 327-3000
(Name,
address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Ruben K. Chuquimia, Esq.
Eric S. Wu, Esq.
Polsinelli PC
100 South
Fourth Street, Suite 1000
St. Louis, Missouri 63102
(314) 889-8000
Approximate
date of commencement of proposed sale to the public:
From time to time after the effective date of this Registration Statement.
If the
only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the
following box. ☒
If this Form is a post-effective amendment to a registration statement filed pursuant to General
Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of “large accelerated filer,” accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
|
|
Large Accelerated Filer
|
|
☒
|
|
Accelerated Filer
|
|
☐
|
|
|
|
|
|
|
Non-Accelerated Filer
|
|
☐ (Do not check if a smaller reporting company)
|
|
Smaller Reporting Company
|
|
☐
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of Each Class of
Securities to be Registered
|
|
Amount
to be
Registered(1)
|
|
Proposed
Maximum
Offering Price
per
Security(1)
|
|
Proposed
Maximum
Aggregate
Offering Price(1)
|
|
Amount of
Registration Fee(1)(2)
|
|
Common Stock, par value $0.001 per share
|
|
|
|
|
|
|
|
|
|
Preferred Stock, par value $0.001 per share
|
|
|
|
|
|
|
|
|
|
Debt Securities
|
|
|
|
|
|
|
|
|
|
Warrants
|
|
|
|
|
|
|
|
|
|
Units(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
An indeterminate amount of securities is being registered pursuant to this registration statement as may from time to time be sold at indeterminate prices. Separate consideration may or may not be received for
securities that are issuable on exercise, conversion or exchange of other securities.
|
|
(2)
|
In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant is deferring payment of all registration fees and will pay the registration fees subsequently on a “pay-as-you-go” basis,
except for $3,864 that the registrant is applying to partially offset the registration fees hereunder, pursuant to Rule 457(p) of the Securities Act, representing registration fees paid with respect to $30,000,000 in aggregate offering price of
unsold securities that were registered pursuant to a Registration Statement on Form S-3 (File No. 333-191986) filed by the registrant on October 30, 2013.
|
|
(3)
|
Each unit will represent an interest in two or more other securities registered hereunder, which may or may not be separable from one another.
|
PROSPECTUS
TTM Technologies, Inc.
Common Stock
Preferred
Stock
Debt Securities
Warrants
Units
We may offer and sell, from time to time, in one or more offerings, our common stock, preferred stock, debt securities, warrants, or any
combination of the foregoing, either individually or as units composed of one or more of the other securities. In addition, selling securityholders to be named in a prospectus supplement may offer and sell, from time to time, in one or more
offerings, these securities.
This prospectus describes the general terms of these securities and the general manner in which these
securities will be offered. The specific terms of any offering will be described in supplements to this prospectus. Any prospectus supplement may also add, update, or change information contained in this prospectus. None of our securities may be
sold without delivery of an applicable prospectus supplement. You should carefully read this prospectus and the applicable prospectus supplement as well as the documents incorporated or deemed to be incorporated by reference in this prospectus
before you invest in these securities.
Investing in our securities involves risks. See “
Risk Factors
” beginning on page 5 before you make
your investment decision.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
The date of
this prospectus is November 14, 2016
TABLE OF CONTENTS
i
ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, utilizing a
“shelf” registration process. Under this shelf registration statement, we or any selling securityholder may, from time to time, offer or sell any combination of the securities described in this prospectus in one or more offerings. This
prospectus provides you with general information regarding the securities that we or any selling securityholder may offer in the future. Each time we or any selling securityholder sell securities, we will provide a prospectus supplement that
contains specific information about the terms of the securities being offered and the manner in which they may be offered. The prospectus supplement may also add, update or change information contained in this prospectus. If there is any
inconsistency between the information in this prospectus and the applicable prospectus supplement, you must rely on the information in the prospectus supplement. You should read both this prospectus and any prospectus supplement together with
additional information described under the heading “Where You Can Find More Information” and “Incorporation of Certain Information by Reference.”
Neither we nor any selling securityholder have authorized anyone to provide you with information different from that contained or incorporated
by reference in this prospectus or any accompanying prospectus supplement or any “free writing prospectus.” We and the selling securityholders are offering to sell, and seeking offers to buy, securities only in jurisdictions in which
offers and sales are permitted. You should assume that the information in this prospectus or any prospectus supplement is accurate only as of the date on the front of the document and that any information we have incorporated by reference is
accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus, such prospectus supplement, or any sale of a security. Our business, financial condition, results of operations, and
prospects may have changed materially since those dates. You should rely only on the information contained or incorporated by reference in this prospectus or any accompanying prospectus supplement.
In this prospectus, the terms “we,” “our,” “the company” and “us” refer to TTM Technologies, Inc. and
its subsidiaries, unless otherwise specified.
1
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the
public from the SEC’s website at
www.sec.gov
. Through our website at
www.ttm.com
, you may access, free of charge, copies of our SEC filings, as soon as reasonably practical after we electronically file them with or
furnish them to the SEC. Information on, or accessible through, our website is expressly not incorporated by reference into, and does not constitute a part of, this prospectus or any accompanying prospectus supplement. You also may read and copy any
document we file with the SEC at the SEC’s public reference room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room.
This prospectus does not contain all of the information included in the registration statement, including certain exhibits and schedules. You
may obtain the registration statement and exhibits to the registration statement from the SEC at the address listed above or from the SEC’s website.
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to incorporate by reference the information we file with the SEC, which means that we can disclose important information to
you by referring you to those documents. The information that we incorporate by reference is considered to be part of this prospectus. Information that we file with the SEC in the future and incorporate by reference in this prospectus automatically
updates and supersedes previously filed information as applicable. Since information that we later file with the SEC will update and supersede previously incorporated information, you should look at all of the SEC filings that we incorporate by
reference to determine if any of the statements in this prospectus or any accompanying prospectus supplement or in any documents previously incorporated by reference have been modified or superseded.
We incorporate by reference into this prospectus the following documents filed by us with the SEC, other than any portion of the respective
filings furnished, rather than filed, under the Securities Exchange Act of 1934, as amended, or the Exchange Act, in accordance with the Exchange Act and applicable SEC rules:
|
|
•
|
|
our Annual Report on Form 10-K for the fiscal year ended December 28, 2015, including the portions of our definitive proxy statement on Schedule 14A filed with the SEC on March 31, 2016 that are incorporated
by reference therein;
|
|
|
•
|
|
our Quarterly Reports on Form 10-Q for the quarters ended March 28, 2016, June 27, 2016 and September 26, 2016;
|
|
|
•
|
|
our Current Reports on Form 8-K filed with the SEC on January 4, 2016, February 9, 2016, March 8, 2016, May 18, 2016, September 27, 2016, October 5, 2016, and
October 20, 2016, and on Form 8-K/A filed with the SEC on July 31, 2015 (but only with respect to Exhibits 99.1 and 99.2); and
|
|
|
•
|
|
the description of our common stock contained in the Registration Statement on Form 8-A filed with the SEC on August 8, 2005, including any amendments or reports filed for the purpose of updating such description.
|
We also incorporate by reference into this prospectus all documents filed by us under Section 13(a), 13(c), 14 or
15(d) of the Exchange Act on or after the date of this prospectus until the offering of the particular securities covered by a prospectus supplement has been terminated or completed, other than any portion of the respective filings that are
furnished, rather than filed, under the applicable SEC rules. This additional information is a part of this prospectus from the date of filing of those documents.
2
You may request a copy of these filings at no cost, by writing or telephoning us as follows:
TTM Technologies, Inc.
Attention:
Corporate Secretary
1665 Scenic Avenue, Suite 250
Costa Mesa, California 92626
(714)
327-3000
3
ABOUT TTM TECHNOLOGIES, INC.
We are a leading global printed circuit board, or PCB, manufacturer, focusing on quick-turn and technologically complex PCBs and
electro-mechanical solutions, or E-M Solutions. We are the largest PCB manufacturer in North America and one of the largest PCB manufacturers in the world, in each case based on revenue, according to the 2015 rankings from N.T. Information LTD, or
NTI. Our common stock is listed on the NASDAQ Global Select Market and is traded under the ticker symbol “TTMI.”
We maintain
our principal executive offices at 1665 Scenic Avenue, Suite 250, Costa Mesa, California 92626. Our telephone number is (714) 327-3000. We maintain a website at
www.ttm.com
. Information on, or accessible through, our website is
neither part of nor incorporated by reference into this prospectus.
4
RISK FACTORS
Investing in our securities involves a high degree of risk. Prior to making a decision about investing in our securities, you should carefully
consider the specific factors discussed under “Risk Factors” in our most recent Annual Report on Form 10-K and each subsequently filed Quarterly Report on Form 10-Q, together with the risk factors contained in our other SEC filings that we
incorporate by reference into this prospectus or that may be included in any applicable prospectus supplement. The risks and uncertainties we have described are not the only ones facing our company. Additional risks and uncertainties not presently
known to us or that we currently deem immaterial may also affect our business operations. The occurrence of any of these known or unknown risks might cause you to lose all or part of your investment in the offered securities.
5
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This prospectus, any prospectus supplement, any related free writing prospectus, and the documents incorporated by reference herein and
therein may contain forward-looking statements regarding future events or our future financial and operational performance, within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E
of the Exchange Act. Forward-looking statements include statements regarding markets for our products; trends in net sales, gross profits and estimated expense levels; liquidity and anticipated cash needs and availability; and any statement that
contains the words “anticipate,” “believe,” “plan,” “forecast,” “foresee,” “estimate,” “project,” “expect,” “seek,” “target,” “intend,”
“goal” and other similar expressions.
The forward-looking statements included in this prospectus, any prospectus supplement,
any related free writing prospectus and the documents incorporated by reference herein and therein reflect our current expectations and beliefs, and we do not undertake publicly to update or revise these statements, even if experience or future
changes make it clear that any projected results expressed in this prospectus, any prospectus supplement, any related free writing prospectus and the documents incorporated by reference herein and therein will not be realized. In addition, the
inclusion of any statement in this prospectus, any prospectus supplement, any related free writing prospectus and the documents incorporated by reference herein and therein does not constitute an admission by us that the events or circumstances
described in such statement are material. Furthermore, we wish to caution and advise readers that these statements are based on assumptions that may not materialize and may involve risks and uncertainties, many of which are beyond our control that
could cause actual events or performance to differ materially from those contained or implied in these forward-looking statements.
Among
the factors that could cause actual results to differ materially are the factors discussed under “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 28, 2015 and each subsequently filed Quarterly Report
on Form 10-Q. We also will include or incorporate by reference in each prospectus supplement important factors that we believe could cause actual results or events to differ materially from the forward-looking statements that we make.
Should one or more known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated, projected, or implied by these
forward-looking statements. You should consider these factors and the other cautionary statements made in this prospectus, any prospectus supplement, any related free writing prospectus or the documents we incorporate by reference herein or therein
as being applicable to all related forward-looking statements wherever they appear in this prospectus, any prospectus supplement, any related free writing prospectus or the documents incorporated by reference. While we may elect to update
forward-looking statements wherever they appear in this prospectus, any prospectus supplement, any related free writing prospectus or the documents incorporated by reference, we do not assume, and specifically disclaim, any obligation to do so,
whether as a result of new information, future events, or otherwise, except as required by law. Because of these uncertainties, you should not place undue reliance on these forward-looking statements.
6
RATIO OF EARNINGS TO FIXED CHARGES
The following table sets forth our ratio of earnings to fixed charges for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months
Ended
September 26,
2016
|
|
|
Year ended
|
|
|
|
|
|
December 28,
2015
|
|
|
December 29,
2014
|
|
|
December 30,
2013
|
|
|
December 31,
2012
|
|
|
December 31,
2011
|
|
|
Ratio of earnings to fixed charges
|
|
|
1.8x
|
|
|
|
1.1x
|
|
|
|
1.9x
|
|
|
|
2.5x
|
|
|
|
—
|
(a)
|
|
|
3.4x
|
|
|
(a)
|
Earnings were not sufficient to cover fixed charges for period indicated. Additional earnings of $169.9 million for the year ended December 31, 2012 would have been required to achieve a ratio of 1:1.
|
For purposes of calculating the ratio of earnings to fixed charges, earnings are defined as pre-tax income from continuing
operations. Fixed charges consist of the sum of (x) interest expense (including amortization of debt discount and deferred financing costs) and capitalized interest; and (y) an estimate of the interest within rental expense.
7
USE OF PROCEEDS
Unless otherwise indicated in the applicable prospectus supplement, we intend to use the net proceeds we receive from sales of securities
offered by us under this prospectus for general corporate purposes, which may include the repayment and refinancing of indebtedness outstanding from time to time and for working capital, capital expenditures, and acquisitions. Pending these uses,
the net proceeds may also be temporarily invested in short-term securities. We will not receive any proceeds from the sale of securities offered by any selling securityholder.
The specific allocations of the proceeds we receive from the sale of securities offered by us will be described in the applicable prospectus
supplement.
8
DESCRIPTION OF COMMON STOCK
This section describes the general terms of our common stock. A prospectus supplement may provide information that is different from this
prospectus. If the information in the prospectus supplement with respect to our common stock being offered differs from this prospectus, you should rely on the information in the prospectus supplement. A copy of our certificate of incorporation, as
amended, has been incorporated by reference from our filings with the SEC as an exhibit to the registration statement of which this prospectus forms a part. Our common stock and the rights of the holders of our common stock are subject to the
applicable provisions of the Delaware General Corporation Law, to which we refer as Delaware law, our certificate of incorporation, as amended, our fourth amended and restated bylaws, as amended, and the rights of the holders of our preferred stock,
if any, as well as some of the terms of our credit agreement and any other outstanding indebtedness.
As of November 2, 2016, under
our certificate of incorporation, as amended, we had the authority to issue 300,000,000 shares of common stock, par value $0.001 per share. As of November 2, 2016, 100,393,160 shares of our common stock were outstanding and were held of record
by approximately 297 stockholders.
The following description of our common stock, and any description of our common stock in a prospectus
supplement may not be complete and is subject to, and qualified in its entirety by reference to, Delaware law and the actual terms and provisions contained in our certificate of incorporation, as amended, and fourth amended and restated bylaws, as
amended, each as amended from time to time.
Voting Rights
Each outstanding share of our common stock is entitled to one vote per share of record on all matters submitted to a vote of stockholders and
to vote together as a single class for the election of directors and in respect of other corporate matters. At a meeting of stockholders at which a quorum is present, for all matters other than the election of directors, all questions shall be
decided by the vote of the holders of a majority of the outstanding shares of stock entitled to vote thereon present in person or by proxy at the meeting, unless the matter is one upon which a different vote is required by express provision of law
or our certificate of incorporation, as amended, or fourth amended and restated bylaws, as amended. Directors will be elected by a plurality of the votes of the shares present at a meeting. Holders of shares of common stock do not have cumulative
voting rights with respect to the election of directors or any other matter.
Dividends
Holders of our common stock are entitled to receive dividends or other distributions when, as, and if declared by our board of directors. The
right of our board of directors to declare dividends, however, is subject to any rights of the holders of other classes of our capital stock, any indebtedness outstanding from time to time, and the availability of sufficient funds under Delaware law
to pay dividends.
Preemptive Rights
The holders of our common stock do not have preemptive rights to purchase or subscribe for any of our capital stock or other securities.
Redemption
The shares of our common
stock are not subject to redemption by operation of a sinking fund or otherwise.
Liquidation Rights
In the event of any liquidation, dissolution, or winding up of our company, after the payment or provisions for payment of all debts and
liabilities of the corporation and all preferential amounts to which the holders of our
9
preferred stock are entitled with respect to the distribution of assets in liquidation, the holders of shares of our common stock are entitled to receive any of our assets available for
distribution to our stockholders ratably in proportion to the number of shares held by them.
Anti-takeover Effects of Certain Provisions of Delaware
Law
We are subject to Section 203 of Delaware Law, which prohibits a Delaware corporation from engaging in any business
combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:
|
|
•
|
|
before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested holder;
|
|
|
•
|
|
upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the
transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and
(ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
|
|
|
•
|
|
on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least
66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.
|
In general, Section 203
defines business combination to include the following:
|
|
•
|
|
any merger or consolidation involving the corporation and the interested stockholder;
|
|
|
•
|
|
any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;
|
|
|
•
|
|
subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;
|
|
|
•
|
|
any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or
|
|
|
•
|
|
the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or through the corporation.
|
In general, Section 203 defines an “interested stockholder” as an entity or person who, together with the person’s
affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.
Shareholders Agreement
In connection
with our acquisition of the PCB business of Meadville Holdings Limited in April 2010, we entered into a shareholders agreement with Mr. Tang Hsiang Chien, or Mr. Tang, Mr. Tang Chung Yen, Tom, or Tom Tang, Ms. Tang Ying Ming,
Mai, or Mai Tang, and Su Sih (BVI) Limited, pursuant to which Mr. Tang and his affiliates have specified board representation rights, governance rights and other rights. Pursuant to the shareholders agreement, we are required to, among other
things, elect to our board of directors one nominee of Mr. Tang and his affiliates (and any such replacement) who is reasonably acceptable to our nominating and corporate governance committee. When Mr. Tang and his affiliates cease to
beneficially own securities representing at least 9.9% of our total voting power entitled to vote on any matter, Mr. Tang and his affiliates
10
cease to have such board representation rights and such director’s resignation is immediately effective. The shareholders agreement terminates automatically on the 181st day following the
time when Mr. Tang, Tom Tang, Mai Tang, Suh Sih (BVI) Limited and any of their respective affiliates cease to beneficially own securities representing at least 9.9% of our total voting power entitled to vote on any matter. For more information
about the shareholders agreement, please see Exhibits 4.6 and 4.7 to our Annual Report on Form 10-K for the fiscal year ended December 28, 2015 and Exhibit 10.2 to our Current Report on Form 8-K filed with the SEC on January 4, 2016.
Listing
Our common stock is listed on
the NASDAQ Global Select Market under the symbol “TTMI.”
Transfer Agent and Registrar
The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company. Its address is 6201 15th Avenue,
Brooklyn, New York 11219, and its telephone number is (800) 937-5449.
11
DESCRIPTION OF PREFERRED STOCK
This section describes the general terms of our preferred stock to which any prospectus supplement may relate. A prospectus supplement will
describe the terms relating to any preferred stock to be offered by us in greater detail and may provide information that is different from terms described in this prospectus. If the information in the prospectus supplement with respect to the
particular preferred stock being offered differs from this prospectus, you should rely on the information in the prospectus supplement. A copy of our certificate of incorporation, as amended, has been incorporated by reference from our filings with
the SEC as an exhibit to the registration statement. A certificate of designation or amendment to our certificate of incorporation, as amended, will specify the terms of the preferred stock being offered, and will be filed or incorporated by
reference as an exhibit to the registration statement before the preferred stock is issued. The following description of our preferred stock, and any description of the preferred stock in a prospectus supplement, may not be complete and is subject
to, and qualified in its entirety by reference to, Delaware law and the actual terms and provisions contained in our certificate of incorporation, as amended, and fourth amended and restated bylaws, as amended, each as amended from time to time.
As of November 2, 2016, under our certificate of incorporation, as amended, we had the authority to issue 15,000,000 shares of
preferred stock, par value $0.001 per share, which are issuable in series on terms to be determined by our board of directors. Accordingly, our board of directors is authorized, without action by the stockholders, to issue preferred stock from time
to time with such dividend, liquidation, conversion, voting, and other rights and restrictions as it may determine. All shares of any one series of our preferred stock will be identical, except that shares of any one series issued at different times
may differ as to the dates from which dividends may be cumulative. All series shall rank equally and shall provide for other terms as described in the applicable prospectus supplement. As of November 2, 2016, there were no outstanding shares of
our preferred stock.
Unless provided in a prospectus supplement, the shares of our preferred stock to be issued will have no preemptive
rights. Any prospectus supplement offering our preferred stock will furnish the following information with respect to the preferred stock offered by that prospectus supplement:
|
|
•
|
|
the title and stated value of the preferred stock;
|
|
|
•
|
|
the number of shares of preferred stock to be issued and the offering price of the preferred stock;
|
|
|
•
|
|
any dividend rates, periods, or payment dates, or methods of calculation of dividends applicable to the preferred stock;
|
|
|
•
|
|
the date from which distributions on the preferred stock shall accumulate, if applicable;
|
|
|
•
|
|
the terms and conditions, if applicable, upon which the preferred stock will be convertible into our common stock, including the conversion price (or manner of calculation thereof);
|
|
|
•
|
|
any right to convert the preferred stock into a different type of security;
|
|
|
•
|
|
any voting rights attributable to the preferred stock;
|
|
|
•
|
|
any rights and preferences upon our liquidation, dissolution or winding up of our affairs;
|
|
|
•
|
|
any terms of redemption;
|
|
|
•
|
|
the procedures for any auction and remarketing, if any, for the preferred stock;
|
|
|
•
|
|
the provisions for a sinking fund, if any, for the preferred stock;
|
|
|
•
|
|
any listing of the preferred stock on any securities exchange;
|
|
|
•
|
|
a discussion of federal income tax considerations applicable to the preferred stock;
|
12
|
|
•
|
|
the relative ranking and preferences of the preferred stock as to distribution rights (including whether any liquidation preference as to the preferred stock will be treated as a liability for purposes of determining
the availability of assets for distributions to holders of stock ranking junior to the shares of preferred stock as to distribution rights);
|
|
|
•
|
|
any limitations on issuance of any series of preferred stock ranking senior to or on a parity with the series of preferred stock being offered as to distribution rights and rights upon the liquidation, dissolution, or
winding up or our affairs; and
|
|
|
•
|
|
any other specific terms, preferences, rights, limitations, or restrictions of the preferred stock.
|
If our board of directors decides to issue any preferred stock, it may discourage or make more difficult a merger, tender offer, business
combination, or proxy contest, assumption of control by a holder of a large block of our securities, or the removal of incumbent management, even if these events were favorable to the interests of stockholders. Our board of directors, without
stockholder approval, may issue preferred stock with voting and conversion rights and dividend and liquidation preferences that may adversely affect the holders of our other equity or debt securities.
13
DESCRIPTION OF DEBT SECURITIES
The debt securities will constitute either senior or subordinated debt of TTM Technologies, Inc. The debt securities that are sold may be
exchangeable for and/or convertible into common stock or any of the other securities that may be sold under this prospectus. The debt securities will be issued under one or more separate indentures between us and a designated trustee. We will
include in a prospectus supplement the specific terms of each series of senior or subordinated debt securities being offered, including the terms, if any, on which a series of senior or subordinated debt securities may be convertible into or
exchangeable for other securities. In addition the material terms of any indenture, which will govern the rights of the holders of our senior or subordinated debt securities will be set forth in the applicable prospectus supplement.
14
DESCRIPTION OF WARRANTS
We may issue, either separately or together with other securities, warrants for the purchase of any of the other types of securities that we
may sell under this prospectus.
The warrants will be issued under warrant agreements to be entered into between us and a bank or trust
company, as warrant agent, all to be set forth in the applicable prospectus supplement relating to any or all warrants in respect of which this prospectus is being delivered. Copies of the form of agreement for each warrant, which we refer to
collectively as “warrant agreements,” including the forms of certificates representing the warrants, which we refer to collectively as “warrant certificates,” and reflecting the provisions to be included in such agreements that
will be entered into with respect to the particular offerings of each type of warrant, will be filed with the SEC and incorporated by reference as exhibits to the registration statement of which this prospectus forms a part.
The following description sets forth certain general terms and provisions of the warrants to which any prospectus supplement may relate. The
particular terms of the warrants to which any prospectus supplement may relate and the extent, if any, to which the general provisions may apply to the warrants so offered will be described in the applicable prospectus supplement. To the extent that
any particular terms of the warrants, warrant agreements or warrant certificates described in a prospectus supplement differ from any of the terms described below, then the terms described below will be deemed to have been superseded by that
prospectus supplement. We encourage you to read the applicable warrant agreement and certificate for additional information before you purchase any of our warrants.
General
The prospectus supplement will
describe the terms of the warrants in respect of which this prospectus is being delivered, as well as the related warrant agreement and warrant certificates, including the following, where applicable:
|
|
•
|
|
the principal amount of, or the number of, securities, as the case may be, purchasable upon exercise of each warrant and the initial price at which the principal amount or number of securities, as the case may be, may
be purchased upon such exercise;
|
|
|
•
|
|
the designation and terms of the securities, if other than common stock, purchasable upon exercise of the warrants and of any securities, if other than common stock, with which the warrants are issued;
|
|
|
•
|
|
the procedures and conditions relating to the exercise of the warrants;
|
|
|
•
|
|
the date, if any, on and after which the warrants, and any securities with which the warrants are issued, will be separately transferable;
|
|
|
•
|
|
the offering price, if any, of the warrants;
|
|
|
•
|
|
the date on which the right to exercise the warrants will commence and the date on which that right will expire;
|
|
|
•
|
|
if applicable, a discussion of the material United States federal income tax considerations applicable to the exercise of the warrants;
|
|
|
•
|
|
whether the warrants represented by the warrant certificates will be issued in registered or bearer form and, if registered, where they may be transferred and registered;
|
|
|
•
|
|
call provisions, if any, of the warrants;
|
|
|
•
|
|
antidilution provisions, if any, of the warrants; and
|
|
|
•
|
|
any other material terms of the warrants.
|
15
The description in the prospectus supplement will not necessarily be complete and will be
qualified in its entirety by reference to the warrant agreement and warrant certificate relating to the warrants being offered.
Exercise of Warrants
Each warrant will entitle the holder to purchase for cash that principal amount of, or number of, securities, as the case may be, at
the exercise price set forth in, or to be determined as set forth in, the applicable prospectus supplement relating to the warrants. Upon receipt of payment and the warrant certificate properly completed and duly executed, we will, as soon as
practicable, issue the securities purchasable upon exercise of the warrant.
No Rights of Security Holder Prior to Exercise
Before the exercise of their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon the
exercise of the warrants, and will not be entitled to:
|
|
•
|
|
in the case of warrants to purchase debt securities, payments of principal of, or any premium or interest on, the debt securities purchasable upon exercise; or
|
|
|
•
|
|
in the case of warrants to purchase equity securities, the right to vote or to receive dividend payments or similar distributions on the securities purchasable upon exercise.
|
16
DESCRIPTION OF UNITS
We may, from time to time, issue units composed of one or more of the other securities that may be offered under this prospectus, in any
combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement
under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately at any time, or at any time before a specified date.
Any applicable prospectus supplement may describe, among other things:
|
|
•
|
|
the material terms of the units and of the securities composing the units, including whether and under what circumstances those securities may be held or transferred separately;
|
|
|
•
|
|
any material provisions relating to the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units;
|
|
|
•
|
|
any special United States federal income tax considerations applicable to the units; and
|
|
|
•
|
|
any material provisions of the governing unit agreement that differ from those described above.
|
17
FORMS OF SECURITIES
Each debt security, warrant and unit will be represented either by a certificate issued in definitive form to a particular investor or by one
or more global securities representing the entire issuance of securities. Certificated securities will be issued in definitive form and global securities will be issued in registered form. Definitive securities name you or your nominee as the owner
of the security, and in order to transfer or exchange these securities or to receive payments other than interest or other interim payments, you or your nominee must physically deliver the securities to the trustee, registrar, paying agent or other
agent, as applicable. Global securities name a depositary or its nominee as the owner of the debt securities, warrants or units represented by these global securities. The depositary maintains a computerized system that will reflect each
investor’s beneficial ownership of the securities through an account maintained by the investor with its broker/dealer, bank, trust company or other representative, as we explain more fully below.
Registered Global Securities
We may
issue the registered debt securities, warrants and units in the form of one or more fully registered global securities that will be deposited with a depositary or its nominee identified in the applicable prospectus supplement and registered in the
name of that depositary or nominee. In those cases, one or more registered global securities will be issued in a denomination or aggregate denominations equal to the portion of the aggregate principal or face amount of the securities to be
represented by registered global securities. Unless and until it is exchanged in whole for securities in definitive registered form, a registered global security may not be transferred except as a whole by and among the depositary for the registered
global security, the nominees of the depositary or any successors of the depositary or those nominees.
If not described below, any
specific terms of the depositary arrangement with respect to any securities to be represented by a registered global security will be described in the prospectus supplement relating to those securities. We anticipate that the following provisions
will apply to all depositary arrangements.
Ownership of beneficial interests in a registered global security will be limited to persons,
called participants, that have accounts with the depositary or persons that may hold interests through participants. Upon the issuance of a registered global security, the depositary will credit, on its book-entry registration and transfer system,
the participants’ accounts with the respective principal or face amounts of the securities beneficially owned by the participants. Any dealers, underwriters or agents participating in the distribution of the securities will designate the
accounts to be credited. Ownership of beneficial interests in a registered global security will be shown on, and the transfer of ownership interests will be effected only through, records maintained by the depositary, with respect to interests of
participants, and on the records of participants, with respect to interests of persons holding through participants. The laws of some states may require that some purchasers of securities take physical delivery of these securities in definitive
form. These laws may impair your ability to own, transfer or pledge beneficial interests in registered global securities.
So long as the
depositary, or its nominee, is the registered owner of a registered global security, that depositary or its nominee, as the case may be, will be considered the sole owner or holder of the securities represented by the registered global security for
all purposes under the applicable indenture, warrant agreement, guaranteed trust preferred security or unit agreement. Except as described below, owners of beneficial interests in a registered global security will not be entitled to have the
securities represented by the registered global security registered in their names, will not receive or be entitled to receive physical delivery of the securities in definitive form and will not be considered the owners or holders of the securities
under the applicable indenture, warrant agreement, guaranteed trust preferred security or unit agreement. Accordingly, each person owning a beneficial interest in a registered global security must rely on the procedures of the depositary for that
registered global security and, if that person is not a participant, on the procedures of the participant through which the person owns its interest, to exercise any rights of a holder under the applicable indenture, warrant agreement, guaranteed
trust preferred security or unit agreement. We understand that under existing industry practices, if we request any
18
action of holders or if an owner of a beneficial interest in a registered global security desires to give or take any action that a holder is entitled to give or take under the applicable
indenture, warrant agreement, guaranteed trust preferred security or unit agreement, the depositary for the registered global security would authorize the participants holding the relevant beneficial interests to give or take that action, and the
participants would authorize beneficial owners owning through them to give or take that action or would otherwise act upon the instructions of beneficial owners holding through them.
Principal, premium, if any, and interest payments on debt securities, and any payments to holders with respect to warrants, guaranteed trust
preferred securities or units, represented by a registered global security registered in the name of a depositary or its nominee will be made to the depositary or its nominee, as the case may be, as the registered owner of the registered global
security. None of TTM Technologies, Inc., the trustees, the warrant agents, the unit agents or any other agent of TTM Technologies, Inc., agent of the trustees or agent of the warrant agents or unit agents will have any responsibility or liability
for any aspect of the records relating to payments made on account of beneficial ownership interests in the registered global security or for maintaining, supervising or reviewing any records relating to those beneficial ownership interests.
We expect that the depositary for any of the securities represented by a registered global security, upon receipt of any payment of principal,
premium, interest or other distribution of underlying securities or other property to holders on that registered global security, will immediately credit participants’ accounts in amounts proportionate to their respective beneficial interests
in that registered global security as shown on the records of the depositary. We also expect that payments by participants to owners of beneficial interests in a registered global security held through participants will be governed by standing
customer instructions and customary practices, as is now the case with the securities held for the accounts of customers in bearer form or registered in “street name,” and will be the responsibility of those participants.
If the depositary for any of these securities represented by a registered global security is at any time unwilling or unable to continue as
depositary or ceases to be a clearing agency registered under the Exchange Act, and a successor depositary registered as a clearing agency under the Exchange Act is not appointed by us within 90 days, we will issue securities in definitive form in
exchange for the registered global security that had been held by the depositary. Any securities issued in definitive form in exchange for a registered global security will be registered in the name or names that the depositary gives to the relevant
trustee, warrant agent, unit agent or other relevant agent of ours or theirs. It is expected that the depositary’s instructions will be based upon directions received by the depositary from participants with respect to ownership of beneficial
interests in the registered global security that had been held by the depositary.
19
SELLING SECURITYHOLDERS
Selling securityholders to be named in a prospectus supplement may, from time to time, offer and sell some or all of our securities held by
them pursuant to this prospectus and the applicable prospectus supplement. Such selling securityholders may sell our securities held by them to or through underwriters, dealers or agents or directly to purchasers or as otherwise set forth in the
applicable prospectus supplement. See “Plan of Distribution.” Such selling securityholders may also sell, transfer or otherwise dispose of some or all of our securities held by them in transactions exempt from the registration requirements
of the Securities Act.
We will provide you with a prospectus supplement, which will, among other things, set forth the name of each
selling securityholder and the number of our securities beneficially owned by such selling securityholders that are covered by such prospectus supplement.
20
PLAN OF DISTRIBUTION
We and/or any selling securityholder may sell the securities described in this prospectus from time to time in one or more of the following
ways:
|
|
•
|
|
through underwriters or dealers, whether individually or through an underwriting syndicate led by one or more managing underwriters;
|
|
|
•
|
|
in “at the market offerings” within the meaning of Rule 415(a)(4) under the Securities Act, to or through a market maker or into an existing trading market, on an exchange or otherwise;
|
|
|
•
|
|
directly to a limited number of purchasers or to a single purchaser;
|
|
|
•
|
|
through a combination of any of those methods of sale.
|
The prospectus supplement with respect
to the offered securities will describe the terms of the offering, including the following:
|
|
•
|
|
the name or names of any underwriters, dealers or agents;
|
|
|
•
|
|
any public offering price;
|
|
|
•
|
|
the proceeds from such sale;
|
|
|
•
|
|
any underwriting discounts or agency fees and other items constituting underwriters’ or agents’ compensation;
|
|
|
•
|
|
any over-allotment options under which underwriters may purchase additional securities from us or from any selling securityholder;
|
|
|
•
|
|
any discounts or concessions allowed or reallowed or paid to dealers; and
|
|
|
•
|
|
any securities exchanges on which the securities may be listed.
|
Any public offering price and
any discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time. In addition, to the extent this prospectus is used by any selling securityholder to resell common stock or other securities, information with
respect to the selling securityholder will be contained in a prospectus supplement to this prospectus, in a post-effective amendment or in filings we make with the SEC under the Exchange Act that are incorporated by reference.
We and/or any selling securityholder may distribute the securities from time to time in one or more of the following ways:
|
|
•
|
|
at a fixed public offering price or prices, which may be changed;
|
|
|
•
|
|
at prices relating to prevailing market prices at the time of sale;
|
|
|
•
|
|
at varying prices determined at the time of sale; or
|
Unless otherwise indicated in the applicable prospectus supplement, if
we or any selling securityholder use underwriters for a sale of securities, the underwriters will acquire the securities for their own account and may be resold as described above. The obligations of the underwriters to purchase the securities will
be subject to the conditions set forth in the applicable underwriting agreement. Unless otherwise indicated in a prospectus supplement, the underwriters will be obligated to purchase all the securities of the series offered if they purchase
21
any of the securities of that series. Underwriters and agents may be customers of, engage in transactions with, or perform services for TTM Technologies, Inc. and its affiliates in the ordinary
course of business. We or any selling securityholder will describe in the prospectus supplement naming the underwriter the nature of any such relationship. We or any selling securityholder may designate agents who agree to use their reasonable
efforts to solicit purchases for the period of their appointment or to sell securities on a continuing basis. We or any selling securityholder may also sell securities directly to one or more purchasers without using underwriters or agents.
Underwriters, dealers, or agents may receive compensation in the form of discounts, concessions, or commissions from us or any selling
securityholder or from purchasers of the securities as their agents in connection with the sale of the securities. These underwriters, dealers, or agents may be considered to be underwriters under the Securities Act. As a result, discounts,
commissions, or profits on resale received by underwriters, dealers, or agents may be treated as underwriting discounts and commissions. Each prospectus supplement will identify any underwriter, dealer, or agent and describe any compensation
received by them from us or any selling securityholder.
Unless otherwise specified in the applicable prospectus supplement, each class or
series of securities will be a new issue with no established trading market, other than our common stock, which is listed on the NASDAQ Global Select Market. We may elect to list any other class or series of securities on any exchange, but we are
not obligated to do so. It is possible that one or more underwriters may make a market in a class or series of securities, but the underwriters will not be obligated to do so and may discontinue any market making at any time without notice. We
cannot give any assurance as to the liquidity of the trading market for any of the securities.
Underwriters, dealers, and agents may be
entitled under agreements entered into with us or any selling securityholder to indemnification against certain civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments they may be required to
make in respect of these liabilities thereof. Underwriters, dealers, and agents and their affiliates may be customers of, may engage in transactions with, or perform services for us in the ordinary course of business for which they receive
compensation.
22
LEGAL MATTERS
The validity of the issuance of the securities offered hereby will be passed upon for us by Polsinelli PC, St. Louis, Missouri.
EXPERTS
The consolidated financial statements of TTM Technologies, Inc. and subsidiaries as of and for the years ended December 28, 2015 and
December 29, 2014, and management’s assessment of the effectiveness of internal control over financial reporting as of December 28, 2015, have been incorporated by reference herein and in the registration statement in reliance upon
the reports of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. The audit report on the consolidated financial statements contains
an explanatory paragraph that refers to the audit of the adjustments to the 2013 consolidated financial statements to retrospectively adjust the disclosures for a change in the composition of reportable segments. However, KPMG LLP was not engaged to
audit, review, or apply any procedures to the 2013 consolidated financial statements other than with respect to such adjustments. The audit report on the effectiveness of internal control over financial reporting as of December 28, 2015,
contains an explanatory paragraph that states management of TTM Technologies, Inc. excluded from its assessment of the effectiveness of internal control over financial reporting as of December 28, 2015, Viasystems Group, Inc.’s internal
control over financial reporting associated with 32% of total assets and 32% of total net sales included in the consolidated financial statements of TTM Technologies, Inc. and subsidiaries as of and for the year ended December 28, 2015. The
audit report also excludes an evaluation of the internal control over financial reporting of Viasystems Group, Inc.
The consolidated
financial statements of TTM Technologies, Inc. for the year ended December 30, 2013, before the effects of the adjustments to retrospectively reflect the change in the composition of reportable segments described in Note 19, included in our
Annual Report on Form 10-K for the year ended December 28, 2015, have been incorporated by reference in this prospectus in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given upon the
authority of said firm as experts in auditing and accounting.
The consolidated financial statements of Viasystems Group, Inc. for the
year ended December 31, 2014 which are included in the Form 8-K/A of TTM Technologies, Inc. filed with the SEC on July 31, 2015, have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in
their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and
auditing.
23
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution
The following table sets forth the fees and expenses payable by the registrant in connection with the offering described in the registration
statement.
|
|
|
|
|
|
|
SEC registration fee
|
|
$
|
|
*
|
|
Listing fees
|
|
|
|
**
|
|
FINRA filing fees
|
|
|
|
**
|
|
Accounting fees and expenses
|
|
|
|
**
|
|
Legal fees and expenses
|
|
|
|
**
|
|
Printing fees
|
|
|
|
**
|
|
Transfer agent and registrar fees
|
|
|
|
**
|
|
Rating agency fees
|
|
|
|
**
|
|
Trustee’s fees and expenses
|
|
|
|
**
|
|
Miscellaneous
|
|
|
|
**
|
|
|
|
|
|
|
|
Total
|
|
$
|
|
**
|
|
|
|
|
|
|
|
*
|
Omitted because the registration fee is being deferred in accordance with Rule 456(b) of the Securities Act, except for $3,864 that the registrant is applying to partially offset the registration fees hereunder,
pursuant to Rule 457(p) of the Securities Act, representing registration fees paid with respect to $30,000,000 in aggregate offering price of unsold securities that were registered pursuant to a Registration Statement on Form S-3 (No. 333-191986)
filed by TTM Technologies, Inc. on October 30, 2013.
|
|
**
|
Not presently known. An estimate of the aggregate expenses in connection with the issuance and distribution of the securities being offered will be included in the applicable prospectus supplement.
|
Item 15. Indemnification of Directors and Officers
Our certificate of incorporation, as amended, and fourth amended and restated bylaws, as amended, limit the liability of directors to the
fullest extent permitted by the Delaware General Corporation Law. In addition, our certificate of incorporation, as amended, and fourth amended and restated bylaws, as amended, provide that we will indemnify our directors and officers to the fullest
extent permitted by law.
Section 145 of the Delaware General Corporation Law empowers a Delaware corporation to indemnify any person
who was or is a party or is threatened to be made a party to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative (other than an action by or in the right of such corporation)
by reason of the fact that such person is or was a director, officer, employee, or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee, or agent of another corporation or enterprise. In
accordance with Delaware law, the certificate of incorporation, as amended, and the fourth amended and restated bylaws, as amended, of the registrant provide that the registrant will indemnify and advance expenses, to the fullest extent permitted by
Delaware law, to each person who is or was a director or officer of the registrant, or who serves or served any other enterprise or organization at the request of the registrant (an “Indemnitee”).
Under Delaware law, to the extent that an Indemnitee is successful on the merits in defense of a suit or proceeding brought against him or her
by reason of the fact that he or she is or was a director, officer, or agent of the registrant, or serves or served any other enterprise or organization at the request of the registrant, the registrant shall indemnify him or her against expenses
(including attorneys’ fees) actually and reasonably incurred in connection with such action.
II-1
If unsuccessful in defense of a third-party civil suit or a criminal suit, or if such a suit is
settled, an Indemnitee may be indemnified under Delaware law against both (i) expenses, including attorneys’ fees, and (ii) judgments, fines, and amounts paid in settlement if he or she acted in good faith and in a manner he or she
reasonably believed to be in, or not opposed to, the best interests of the registrant, and, with respect to any criminal action, had no reasonable cause to believe his or her conduct was unlawful.
If unsuccessful in defense of a suit brought by or in the right of the registrant, where the suit is settled, an Indemnitee may be indemnified
under Delaware law only against expenses (including attorneys’ fees) actually and reasonably incurred in the defense or settlement of the suit if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not
opposed to, the best interests of the registrant except that if the Indemnitee is adjudged to be liable for negligence or misconduct in the performance of his or her duty to the registrant, he or she cannot be made whole even for expenses unless a
court determines that he or she is fully and reasonably entitled to indemnification for such expenses.
Also under Delaware law, expenses
incurred by an officer or director in defending a civil or criminal action, suit, or proceeding may be paid by the registrant in advance of the final disposition of the suit, action, or proceeding upon receipt of an undertaking by or on behalf of
the officer or director to repay such amount if it is ultimately determined that he or she is not entitled to be indemnified by the registrant. The registrant may also advance expenses incurred by other employees and agents of the registrant upon
such terms and conditions, if any, that the board of directors of the registrant deems appropriate.
We carry insurance policies insuring
our directors and officers against certain liabilities that they may incur in their capacity as directors and officers. In addition, we have entered into indemnification agreements with each of our directors.
Any underwriting agreement that the Registrant may enter into in connection with the sale of any securities registered hereunder may provide
for indemnification of directors and certain officers of the Registrant by the underwriters against certain liabilities. To the extent that the Registrant enters into any such underwriting agreement, the Registrant will file it as an exhibit to a
Current Report on Form 8-K, which will be incorporated by reference into this registration statement.
Item 16. Exhibits
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
1.1
|
|
Form of Underwriting Agreement*
|
|
|
|
|
2.1
|
|
Agreement and Plan of Merger, dated as of September 21, 2014, by and among the Company, Viasystems Group, Inc. and Vector Acquisition Corp., incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on
September 22, 2014, SEC File Number 000-31285**
|
|
|
|
|
3.1
|
|
Certificate of Incorporation, as amended, incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on June 6, 2011, SEC File Number 000-31285
|
|
|
|
|
3.2
|
|
Certificate of Amendment of Certificate of Incorporation, incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on May 18, 2016, SEC File Number 000-31285
|
|
|
|
|
3.3
|
|
Fourth Amended and Restated Bylaws, as amended, incorporated by reference to Exhibit 3.2(i) to the Company’s Form 8-K filed on March 8, 2016, SEC File Number 000-31285
|
|
|
|
|
4.1
|
|
Indenture, dated as of December 20, 2013, between the Company and American Stock Transfer & Trust Company, LLC, as Trustee, incorporated by reference to Exhibit 4.8 to the Company’s
Form 8-K
filed on December 20, 2013, SEC File Number 000-31285
|
II-2
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
4.2
|
|
Form of Registrant’s common stock certificate, incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K filed on August 30, 2005, SEC File Number 000-31285
|
|
|
|
|
4.3
|
|
Specimen preferred stock certificate*
|
|
|
|
|
4.4
|
|
Form of Indenture relating to Debt Securities, incorporated by reference to Exhibit 4.11 to the Company’s Registration Statement on Form S-3 filed on October 30, 2013, SEC File
No. 333-191986
|
|
|
|
|
4.5
|
|
Form of Debt Security*
|
|
|
|
|
4.6
|
|
Form of Warrant Agreement and Certificate*
|
|
|
|
|
4.7
|
|
Form of Unit Agreement and Certificate*
|
|
|
|
|
5.1
|
|
Opinion of Polsinelli PC
|
|
|
|
|
12.1
|
|
Statement of Computation of Ratio of Earnings to Fixed Charges
|
|
|
|
|
23.1
|
|
Consent of KPMG LLP
|
|
|
|
|
23.2
|
|
Consent of PricewaterhouseCoopers LLP
|
|
|
|
|
23.3
|
|
Consent of Ernst & Young LLP
|
|
|
|
|
23.4
|
|
Consent of Polsinelli PC (included in Exhibit 5.1)
|
|
|
|
|
24.1
|
|
Power of Attorney of Directors and Executive Officers (included on signature page hereto)
|
|
|
|
|
25.1
|
|
Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939 of the Trustee under the Indenture*
|
|
*
|
To be filed, if necessary, either by amendment to the Registration Statement or as an exhibit to a Current Report on Form 8-K and incorporated by reference herein.
|
|
**
|
Schedules and/or exhibits not filed will be furnished to the SEC upon request, pursuant to Item 601(b)(2) of Regulation S-K.
|
Item 17. Undertakings
(a) The
undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective
registration statement.
(iii) to include any material information with respect to the plan of distribution not previously disclosed in
the registration statement or any material change to such information in the registration statement;
II-3
provided, however, that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) of this section do not apply if the
information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange
Act of 1934 that are incorporated by reference into the registration statement or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.
(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:
(i) If the registrant is relying on Rule 430B:
(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date
the filed prospectus was deemed part of and included in the registration statement; and
(B) Each prospectus required to be filed
pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of this registration statement or in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by
Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier date such form of prospectus is first used after effectiveness or the date of the first contract of sale of
securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration
statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof. Provided, however,
that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or
made in any such document immediately prior to such effective date.
(ii) If the registrant is subject to Rule 430C, each prospectus
filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included
in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or
deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was
made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.
(5) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial
distribution of securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to
the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such
purchaser:
(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed
pursuant to Rule 424;
II-4
(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the
undersigned registrant or used or referred to by the undersigned registrant;
(iii) The portion of any other free writing prospectus
relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
(b) For an offering in which the securities to be registered are to be offered to existing security holders pursuant to warrants and any
securities not taken by security holders are to be reoffered to the public, the undersigned registrant hereby undertakes to supplement the prospectus, after the expiration of the subscription period, to set forth the results of the subscription
offer, the transactions by the underwriters during the subscription period, the amount of unsubscribed securities to be purchased by the underwriters, and the terms of any subsequent reoffering thereof. If any public offering by the underwriters is
to be made on terms differing from those set forth on the cover page of the prospectus, a post-effective amendment will be filed to set forth the terms of such offering.
(c) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of
the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial
bona fide
offering thereof.
(d) Insofar as indemnification for liabilities arising
under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the
registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the
Act and will be governed by the final adjudication of such issue.
(e) The undersigned registrant hereby undertakes that:
(1) For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as
part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration
statement as of the time it was declared effective.
(2) For the purpose of determining any liability under the Securities Act of 1933,
each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
(f) The undersigned registrant hereby undertakes to file an application for the purpose of determining the
eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act, or the Act, in accordance with the rules and regulations prescribed by the Commission under section 305(b)(2) of the Act.
II-5
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Costa Mesa, State of California, on the 14th day of November,
2016.
|
|
|
|
|
TTM TECHNOLOGIES, INC.
|
|
|
|
|
By:
|
|
/s/ Thomas T. Edman
|
|
|
|
Name: Thomas T. Edman
|
|
|
|
Title: President and Chief Executive Officer
|
KNOW ALL PERSONS BY THESE PRESENTS
, that each person whose signature appears below constitutes
and appoints Todd B. Schull and Daniel J. Weber and each of them acting alone, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead,
in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to sign any registration statement and amendments thereto for the same offering pursuant to Rule 462(b) under the
Securities Act of 1933, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and
authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all which said
attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do, or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities and on the dates indicated:
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Thomas T. Edman
Thomas T. Edman
|
|
President, Chief Executive Officer and Director
(Principal Executive Officer)
|
|
November 14, 2016
|
|
|
|
|
|
/s/ Todd B. Schull
Todd B. Schull
|
|
Executive Vice President, Chief Financial Officer
and Treasurer (Principal Financial Officer and
Principal Accounting Officer)
|
|
November 14, 2016
|
|
|
|
|
|
/s/ Robert Klatell
Robert Klatell
|
|
Chairman of the Board
|
|
November 14, 2016
|
|
|
|
|
|
/s/ Kenton K. Alder
Kenton K. Alder
|
|
Director
|
|
November 14, 2016
|
|
|
|
|
|
/s/ James K. Bass
James K. Bass
|
|
Director
|
|
November 14, 2016
|
|
|
|
|
|
/s/ Julie S. England
Julie S. England
|
|
Director
|
|
November 14, 2016
|
|
|
|
|
|
/s/ Philip G. Franklin
Philip G. Franklin
|
|
Director
|
|
November 14, 2016
|
II-6
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Ronald W. Iverson
Ronald W. Iverson
|
|
Director
|
|
November 14, 2016
|
|
|
|
|
|
/s/ John G. Mayer
John G. Mayer
|
|
Director
|
|
November 14, 2016
|
|
|
|
|
|
/s/ Tang Chung Yen, Tom
Tang Chung Yen, Tom
|
|
Director
|
|
November 14, 2016
|
|
|
|
|
|
/s/ Dov S. Zakheim
Dov S. Zakheim
|
|
Director
|
|
November 14, 2016
|
II-7
EXHIBIT INDEX
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
1.1
|
|
Form of Underwriting Agreement*
|
|
|
|
|
2.1
|
|
Agreement and Plan of Merger, dated as of September 21, 2014, by and among the Company, Viasystems Group, Inc. and Vector Acquisition Corp., incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on
September 22, 2014, SEC File Number 000-31285**
|
|
|
|
|
3.1
|
|
Certificate of Incorporation, as amended, incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on June 6, 2011, SEC File Number 000-31285
|
|
|
|
|
3.2
|
|
Certificate of Amendment of Certificate of Incorporation, incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on May 18, 2016, SEC File Number 000-31285
|
|
|
|
|
3.3
|
|
Fourth Amended and Restated Bylaws, as amended, incorporated by reference to Exhibit 3.2(i) to the Company’s Form 8-K filed on March 8, 2016, SEC File Number 000-31285
|
|
|
|
|
4.1
|
|
Indenture, dated as of December 20, 2013, between the Company and American Stock Transfer & Trust Company, LLC, as Trustee, incorporated by reference to Exhibit 4.8 to the Company’s Form
8-K
filed on December 20, 2013, SEC File Number 000-31285
|
|
|
|
|
4.2
|
|
Form of Registrant’s common stock certificate, incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K filed on August 30, 2005, SEC File Number 000-31285
|
|
|
|
|
4.3
|
|
Specimen preferred stock certificate*
|
|
|
|
|
4.4
|
|
Form of Indenture relating to Debt Securities, incorporated by reference to Exhibit 4.11 to the Company’s Registration Statement on Form S-3 filed on October 30, 2013, SEC File No.
333-191986
|
|
|
|
|
4.5
|
|
Form of Debt Security*
|
|
|
|
|
4.6
|
|
Form of Warrant Agreement and Certificate*
|
|
|
|
|
4.7
|
|
Form of Unit Agreement and Certificate*
|
|
|
|
|
5.1
|
|
Opinion of Polsinelli PC
|
|
|
|
|
12.1
|
|
Statement of Computation of Ratio of Earnings to Fixed Charges
|
|
|
|
|
23.1
|
|
Consent of KPMG LLP
|
|
|
|
|
23.2
|
|
Consent of PricewaterhouseCoopers LLP
|
|
|
|
|
23.3
|
|
Consent of Ernst & Young LLP
|
|
|
|
|
23.4
|
|
Consent of Polsinelli PC (included in Exhibit 5.1)
|
|
|
|
|
24.1
|
|
Power of Attorney of Directors and Executive Officers (included on signature page hereto)
|
|
|
|
|
25.1
|
|
Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939 of the Trustee under the Indenture*
|
|
*
|
To be filed, if necessary, either by amendment to the Registration Statement or as an exhibit to a Current Report on Form 8-K and incorporated by reference herein.
|
|
**
|
Schedules and/or exhibits not filed will be furnished to the SEC upon request, pursuant to Item 601(b)(2) of Regulation S-K.
|
II-8
TTM Technologies (NASDAQ:TTMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
TTM Technologies (NASDAQ:TTMI)
Historical Stock Chart
From Apr 2023 to Apr 2024
